Alyssa R.M. Pugh is a registered patent attorney focusing her practice on intellectual property (IP) matters involving the life sciences, with an emphasis on patent prosecution strategies in the biopharma, biochemical, food science, and medical device industries. With a background in genetics and developmental biology, her practice encompasses a wide variety of technical subject matter, including pharmaceutical formulations, therapeutic regimens, nutritional supplements, food chemistry, transgenic organisms, and recombinant DNA technology.
Alyssa provides counseling for both domestic and international matters related to patent prosecution. She has extensive experience in conducting due diligence, invalidity, and freedom-to-operate analyses. She has engaged in developing and expanding patent portfolios for small biotechnology startups and universities, as well as managing and coordinating prosecution of large, worldwide patent portfolios for international corporations. Alyssa has also provided both legal and technical support for projects related to FDA compliance for nutritional supplements and nutriceuticals.
Prior to joining Morgan Lewis, Alyssa was an associate at a Pennsylvania-based intellectual property boutique, where she focused on biomedical device technology and chemical formulations patent matters.
Villanova University Charles Widger School of Law, 2014, J.D., cum laude
Pennsylvania State University, 2011, B.S., Biology (Genetics and Developmental Biology Option), with Honors
US District Court for the Eastern District of Pennsylvania
US Patent and Trademark Office
Extern to Magistrate Judge Mary Pat Thynge of the US District Court for the District of Delaware (2013)
Awards and Affiliations
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Member, Litigation Department of the Year–Intellectual Property, The American Lawyer (2019)